Jo Viney is an experienced biotech executive and entrepreneurial scientist who has taken 13 drugs to clinic. She is Founder, President and CEO of Seismic Therapeutics, the machine learning immunology company. Prior to founding Seismic, she founded Pandion Therapeutics in 2017 and served as President and CSO until the acquisition by Merck for $1.85B in 2021. Prior to founding Pandion, she worked at Biogen, Amgen, and Immunex. Jo is an independent board director for Finch Therapeutics, Harpoon Therapeutics, Graphite Bio and Lab Central. Jo is an advocate for workplace inclusiveness, and has served on the board of Women in the Enterprise of Science & Technology (WEST), a non-profit organization supporting early to mid-career women, including as President 2017-18.